ARTICANZ - Beta (ver 0.91)

Annotated Registry of Trials in Cancer, Australia and New Zealand Ed. - Results - target/MET-inhibitor-type-1

Search results

target/MET-inhibitor-type-1
6 trial(s) found.
NCT05987332
NCT05261399
3220 - Geelong - Andrew Love Cancer Centre, University Hospital Geelong (WITHDRAWN)
NCT03947385
NCT03175224
ACTRN12621000991819
Not Applicable
ACTRN12616001187437
Filters
MET
100%
ALK
67%
ROS1
67%
EGFR
50%
PKC
33%
MEK
33%
BCR-ABL1
33%
CDK4
33%
CDK6
33%
CRAF
33%
FLT3
33%
KIT
33%
PDGFR
33%
PDGFRA
33%
RAF
33%
SRC
33%
VEGFR
33%
YES1
33%
mTOR
33%
mTORC1
33%
CTLA4
17%
PD-1
17%
PD-1/PD-L1
17%
ATR
17%
JAK1
17%
JAK2
17%
PI3K
17%
SMO
17%
mTORC2
17%
AXL
17%
ERBB2
17%
FGFR1
17%
FGFR1/2/3
17%
FGFR2
17%
FGFR3
17%
FGFR4
17%
HDAC
17%
IGF1R
17%
PARP
17%
RET
17%
VEGFR2
17%
proteasome
17%




















 






























	
		
	

    

        

			ARTICANZ (Annotated Registry of Trials in Cancer, Australia/NZ Edition; ARTificial Intelligence-enhanced CANcer trial information database) provides information about cancer drug trials in Australia and New Zealand as a free, open-information platform. Please note the following:

			
    
			
  • Data Accuracy: While ARTICANZ strives to maintain accurate and up-to-date information through regular weekly updates and specialist review, we cannot guarantee the complete accuracy, reliability, or timeliness of all data. Information may change between updates.
    • 
			
			
  • Not Medical Advice: The information provided by ARTICANZ is for informational purposes only and should not be considered medical advice. All clinical decisions should be made in consultation with qualified healthcare professionals.
    • 
			
			
  • No Warranty: ARTICANZ is provided "as is" without any warranties, expressed or implied. We disclaim all liability for any damages arising from the use of or inability to use this platform.
    • 
			
			
  • External Links: ARTICANZ may contain links to external websites. We are not responsible for the content or privacy practices of these sites.
    • 
			
			


			By using ARTICANZ, you acknowledge that you have read and understood this disclaimer.
			
		

        

            
The ARTICANZ platform and its contents are made available under the Creative Commons Attribution 4.0 International License (CC BY 4.0).

            
            
Users are free to:

            
    
                
  • Share — copy and redistribute the data in any medium or format
    • 
                
  • Adapt — remix, transform, and build upon the data
    • 
                
  • Use the data for any purpose, including commercial use
    • 
            

            
            
Under the following terms:

            
    
                
  • Attribution — You must give appropriate credit to ARTICANZ, provide a link to the license, and indicate if changes were made
    • 
                
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits
    • 
            

            
            
Platform developed and currently maintained by Dr. Frank Lin and the ARTICANZ team.